Free Trial
ASX:SHL

Sonic Healthcare (SHL) Stock Price, News & Analysis

Sonic Healthcare logo

About Sonic Healthcare Stock (ASX:SHL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.46 million shs
Average Volume
N/A
Market Capitalization
$13.84 billion
P/E Ratio
26.85
Dividend Yield
3.68%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Receive SHL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sonic Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SHL Stock News Headlines

Morgans Sticks to Their Buy Rating for Sonic Healthcare Limited (SHL)
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.
Jefferies Keeps Their Hold Rating on Sonic Healthcare Limited (SHL)
See More Headlines

SHL Stock Analysis - Frequently Asked Questions

Sonic Healthcare Limited (ASX:SHL) released its quarterly earnings results on Wednesday, February, 20th. The health services provider reported $0.52 EPS for the quarter, missing analysts' consensus estimates of $0.56 by $0.04. Sonic Healthcare had a net margin of 5.72% and a trailing twelve-month return on equity of 6.54%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonic Healthcare investors own include CSL (CSL), BHP Group (BHP), Commonwealth Bank of Australia (CBA), Contact Energy (CEN), Fortescue (FMG), Meta Platforms (META) and Mineral Resources (MIN).

Company Calendar

Last Earnings
2/20/2019
Today
2/23/2025
Ex-Dividend for 3/19 Dividend
3/04/2025
Dividend Payable
3/19/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
41,000
Year Founded
N/A

Profitability

Net Income
$511.09 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.97 billion
Book Value
A$16.96 per share

Miscellaneous

Free Float
N/A
Market Cap
$13.84 billion
Optionable
Not Optionable
Beta
0.51
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ASX:SHL) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners